11/03/2026
Isotope Days 2026: X-Nuclei MRS and Imaging
How can stable isotopes and hyperpolarization show us what tumors are doing, as it happens? Join four leading researchers for a free webinar on the latest advances in X-nuclei magnetic resonance and metabolic imaging.
Speakers and talks:
Franz Schilling, PhD, Technical University Munich
Molecular MRI of Metabolism, pH and Cell Death
pH-sensitive hyperpolarized probes, multimodal metabolic imaging, and diffusion MRI for detecting early cell death, plus how these biomarkers move from preclinical work into the clinic.
Kumar Pichumani, PhD, Houston Methodist Research Institute
Probing Nutrient Utilization in Human Brain Tumors Using ¹³C Isotopomer Analysis
Intraoperative ¹³C tracing with glucose, acetate, glutamine and β-hydroxybutyrate, and what it reveals about metabolic vulnerabilities in gliomas, meningiomas and pediatric brain tumors.
Eduard Chekmenev, PhD, Wayne State University
High-Throughput Pyruvate-to-Lactate Flux Profiling Using All-Benchtop SABRE Hyperpolarization and 1.4 T ¹³C NMR
Real-time glycolytic flux measurements in leukemia and breast cancer models, including chemotherapy resistance in AML, all on benchtop instruments.
Henk De Feyter, PhD, Yale University
Deuterium Metabolic Imaging (DMI) to Characterize Brain Tumors in vivo
The fundamentals of ²H MR detection, [6,6'-²H₂]-glucose DMI in patients, and new non-glucose DMI agents.
Moderated by Roswell Shelhamer, Business Development Manager, Cambridge Isotope Laboratories, Inc.
December 3, 2026
Register here: https://cil.isotope.com/acton/fs/blocks/showLandingPage/a/8794/p/p-0149/t/page/fm/1?sid=TV2:iiPdEGc%E2%80%A6